- Home
- Johnson & Johnson
Johnson & Johnson
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
3 innovative ways one company is helping rethink how we treat mental healthcare
From scientists in research labs to CEOs at companies across the country, here’s how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
He helped pioneer robotic surgery. Now he wants to reinvent lung cancer care
Frederic Moll, M.D., has been called “the father of robotic surgery” for good reason—his inventions have helped pave the way for improved surgical procedures for decades. His new challenge: an innovation that has the potential to diagnose and treat disease at the same time.
A vaccine for E. coli? Meet a researcher hot on the trail
A particular strain of the bacteria can be deadly for those over the age of 60—and it’s not the kind that causes food poisoning. But this Janssen researcher is committed to finding a preventive treatment.
The Green Graph: 8 innovative ways Johnson & Johnson is helping the environment
Creative recycling initiatives. Global sustainability pledges. Innovative products. In honor of Earth Day, we’re taking a look at how the company is helping to increase recycling, reduce environmental impact and boost sustainability.
From Aha! moment to FDA approval: The fascinating story behind a new treatment for bladder cancer
For National Cancer Prevention Month, we retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of bladder cancer to patients who may benefit most.
“I had four strokes and two brain surgeries—and survived”
Lisa Deck was just 21 when she had her first stroke. She would go on to have three more, as well as face a rare diagnosis of moyamoya disease. For World Stroke Day, we’re sharing her incredible story of survival and living with a chronic illness.
How Johnson & Johnson is helping tackle a devastating tropical disease that impacts kids
A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.
These 6 university researchers are ready to change the world with their inventions
They’re the winners of the second annual Johnson & Johnson WiSTEM2D Scholars Award, thanks to such amazing innovations as tattoos that can monitor changes in your metabolism. Meet them and their groundbreaking work.
Johnson & Johnson named a LinkedIn Top Company for 2019
The LinkedIn list recognizes companies in the U.S. where people most want to work. And this year, Johnson & Johnson is also featured on the Brazil, Japan and UK lists.